Clinical Trials Logo

Deafness clinical trials

View clinical trials related to Deafness.

Filter by:

NCT ID: NCT03552224 Completed - Hearing Loss Clinical Trials

Evaluation of the Global Auditory Nerve Activity for Exploration of Hearing in Humans

MELAUDI-2
Start date: July 11, 2018
Phase: N/A
Study type: Interventional

To date, all the electrophysiological methods for auditory testing rely on the measure on synchronous evoked auditory nerve activity. This measure only takes into account the response of the first action potential in every auditory fibber, but provides no information about the neural response during a sustained activity. This can explain why in experimental models, a loss of more of 80% of auditory nerve fibbers cannot be detected by usual electrophysiological measurements. In this study we aim at investigating the global spontaneous and sound evoked auditory nerve activity by recording directly the electrical field by an electrode placed directly on the auditory nerve of subjects during a skull base surgical procedure. We expected to demonstrated differences in the electrical activity between subjects with or without hearing loss.

NCT ID: NCT03509974 Completed - Clinical trials for Unilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis)

Early Experience of a New Implant System for Bone Conduction Hearing in the Pediatric Population

OSIA Pediatric
Start date: April 18, 2018
Phase: N/A
Study type: Interventional

To study the initial experience with implanting and fitting a new Bone Conduction system in pediatric patient population with conductive, mixed or single-sided deafness.

NCT ID: NCT03487757 Completed - Postural Control Clinical Trials

"Core Stabilization Exercises in Hearing Impaired Children"

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

In this study the investigators will examine the effects of core stabilization exercises on respiratory muscle strength, respiratory functions and postural control in hearing-impaired children.

NCT ID: NCT03483428 Completed - Hearing Loss Clinical Trials

Adaptation and Pilot Testing of a Behavioral Parent Training Program for Parents of Deaf and Hard of Hearing Children

Start date: April 11, 2018
Phase: N/A
Study type: Interventional

Despite being more likely than typical hearing children to experience disruptive behavior problems, children who are deaf and hard of hearing (DHH) rarely receive behavioral interventions to prevent the long-term costly outcomes of behavior problems. This pilot project will systematically adapt an evidence-based behavioral parent training (BPT) intervention to increase its acceptability and relevance for parents of young DHH children. Two parents of DHH children will be trained in the adapted BPT for DHH children. They will each deliver the intervention to five families with DHH preschool-aged children.

NCT ID: NCT03442296 Completed - Clinical trials for Personal Communication

Baltimore HEARS: Hearing Health Equity Through Accessible Research & Solutions

HEARS
Start date: April 18, 2018
Phase: N/A
Study type: Interventional

Age-related hearing loss is highly prevalent and hearing health care is underutilized. The primary objective of the proposed randomized controlled trial is to investigate the efficacy of a community health worker (CHW)-delivered hearing loss intervention program. A preceding pilot study demonstrated preliminary effectiveness of the intervention program in reducing self-reported hearing handicap, and highlighted its acceptability among the target demographic. The proposed trial will now expand upon lessons learned through previous pilot studies and expand to other affordable residences for low-to-moderate income older adults in Baltimore. Primary outcome measurements will investigate intervention effects on hearing handicap, with secondary measurements investigating effects on domains such as social isolation and quality of life. This trial is a first-in-kind investigation of a novel community-based intervention that addresses hearing loss in a vulnerable, urban population.

NCT ID: NCT03402932 Completed - Clinical trials for Cognitive Impairment

Administration Method of Cognitive Screening in Older Individuals With Hearing Loss

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The objectives of the current project aim to determine whether a more controlled amplification method or a visual administration has an effect on hearing impaired older individuals' cognitive test scores.

NCT ID: NCT03374787 Completed - Clinical trials for Conductive Hearing Loss

Evaluation of Sound Processor for a Transcutaneous System

Start date: November 15, 2017
Phase: N/A
Study type: Interventional

A single center study evaluating the performance of an externally worn sound processor for a transcutaneous bone anchored hearing system using audiological outcomes measures such as aided thresholds and speech intelligibility and self evaluation questionnaires.

NCT ID: NCT03351023 Completed - Hearing Loss Clinical Trials

Healthful Diets and Risk of Hearing Loss

Start date: July 1, 1991
Phase: N/A
Study type: Observational

To prospectively examine the relations between adherence scores for three healthful dietary patterns, the Alternate Mediterranean diet (AMED), the Dietary Approaches to Stop Hypertension (DASH), and the Alternative Healthy Eating Index (AHEI-2010), and risk of hearing loss in the Nurses' Health Study II.

NCT ID: NCT03333577 Completed - Clinical trials for Hearing Loss, Conductive

Evaluation of the Baha SoundArc in Pediatric Patients

Start date: November 2, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to gather clinical performance data on the Baha SoundArc

NCT ID: NCT03331627 Completed - Acute Hearing Loss Clinical Trials

Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL

Start date: February 24, 2018
Phase: Phase 3
Study type: Interventional

a multicenter, double-blind, placebo-controlled study in patients with Sudden Sensorineural Hearing Loss (SSHL). Patients will be treated with STR001 thermogel (STR001-IT) / STR001 tablets (STR001-ER) and corresponding Placebo on top of standard of care.